| n | e | w | . | h | a | v | e | n | . | h | e | a | l | t | h |
|---|
1. Griswold MH. The cancer program in Connecticut. The Journal of the American Medical Association 110:221B-224B, 1938.
2. Macdonald EJ. The cancer situation in Connecticut. Conn Health Bulletin March 1942.
3. Griswold MH. A cancer program in action. Monthly Health Bulletin 57:6:131-133, 1943.
4. Macdonald EJ. Eight years' experience in cancer in twenty-one Conn. hospitals. The Conn. State Medical Journal VII:8:536, 1943.
5. Macdonald EJ. Improvements in services rendered in Conn. hospitals to individuals with cancer. Conn. Health Bulletin 57:8, 1943.
6. Macdonald E. Facts about cancer. Conn. Health Bulletin 57:9, 1943.
7. Macdonald E. Survival rates of individuals who have had proved cancer in Connecticut 1935-1942. Conn. Health Bulletin 58:11, 1944.
8. Macdonald EJ. The state-wide cancer record registry in Connecticut. The Medical Woman's Journal. April, 1944.
9. Macdonald E. A report of living individuals who had proved cancer. Conn. Health Bulletin 58:4, 1944.
10. Macdonald E. Connecticut as a cooperative entity for the control of cancer. Conn. Health Bulletin 58:8, 1944.
11. Griswold MH. Research is key to Conn. system of cancer control. HOSPITAL, The Journal of the American Hospital Association 18:8, 1944.
12. Griswold MH. The expansion of the Conn. cancer program. The Conn. State Medical Journal X:1:18, 1946.
13. Griswold MH. Cancer of the prostate in Connecticut. Conn. State Medical Journal X:2:106, 1946.
14. Griswold MH. Cancer recorded from each town in state. Conn. Health Bulletin 60:4:90-92, 1946.
15. Martin H. Mouth cancer and the dentist. The Journal of the American Dental Association 33:845-861, 1946.
16. Macdonald E. Meaning of adjusted rates for cancer. Conn. Health Bulletin 60:12, 1946.
17. Macdonald EJ. Chanding reasons for cancer patient delay. Conn. Health Bulletin 61:4, 1947.
18. Griswold MH, Macdonald EJ. The Conn. Cancer Record Registry - How it functions. The Conn. State Medical Journal XI:5:344, 1947.
19. Macdonald E. The incidence of cancer of the breast among women. Conn. Health Bulletin 66:7, 1947.
20. Griswold MH. A mutual educational program. Conn. Health Bulletin 61:12, 1947.
21. Macdonald EJ. Malignant melanoma in Connecticut Special Publication of the New York Academy of Sciences IV:71-81, 1948.
22. Macdonald E. The estimated number of individuals treated for cancer needing nursing service. Conn. Health Bulletin 62:3, 1948.
23. Macdonald E. The present incidence and survival picture in cancer and the promise of improved prognosis. Bulletin of American College of Surgeons 33:2:75, 1948.
24. Griswold MH. Evaluation of cancer control methods in Conn. The Journal of the American Medical Association 138:881-884, 1948.
25. Ottenheimer EJ. Cancer of the colon and rectum. Conn. State Med. Journal Suppl. 12:1086-1090, 1948.
26. Cancer, A Handbook for Dentists. (Prepared by The Tumor Committee of the Connecticut State Dental Society). 1948.
27. Pollack ES. Cancer case reporting in relation to deaths from cancer. Conn. Health Bulletin 64:4, 1950.
28. Haenszel WM. Trends in Connecticut vital statistics - XVII. Mortality from cancer. Conn. Health Bulletin 64:4, 1950.
29. Wilder CC. Male and female cancer mortality trends in Connecticut, 1937-1948. Conn. Health Bulletin 64:6, 1950.
30. Cancer in Connecticut - 1949. (Prepared by staff of Div. of Cancer and Other Diseases - M.H. Griswold, M.D. Chief). Monograph, 1950.
31. Griswold MH. Fifteen years' experience with the Conn. Cancer Registry. Conn. Health Bulletin 65:2, 1951.
32. Wilder CS. Incidence and the Connecticut Control Program. Conn. Health Bulletin 65:4, 1951.
33. Pollack ES. Lymphomas: Fifteen years' experience in Conn. Conn. Health Bulletin 66:4, 1952.
34. Griswold MH. Cancer of the prostate in infants and children. Journal of the American Medical Association 150:791, 1952.
35. Griswold MH. Cancer morbidity records. The Journal of the Michigan State Medical Society 52:274-275, 1953.
36. Pollack ES. Cancer survival picture brightens. Conn. Health Bulletin 67:4, 1953.
37. Wilder CS. Cancer in Conn. towns: I. Cases reported by hospitals. Conn. Health Bulletin 67:8, 1953.
38. Wilder CS. Cancer in Conn. Towns: II. Mortality from cancer. Conn. Health Bulletin 67:1, 1953.
39. Cancer in Connecticut - 1950. (Prepared by staff of the Div. of Cancer and Other Chronic Diseases - M.H. Griswold, M.D., Chief). Published in 1953.
40. Pollack ES. The effect of age and site on life expectancy of cancer patients. Conn. Health Bulletin 68:4, 1954.
41. Griswold MH. Lung cancer in Conn. on increase. Conn Health Bulletin 69:65, 1955.
42. Ottenheimer EJ, Oughterson A W. Observations on cancer of the colon and rectum in Connecticut - An analysis based on 5572 proved cases. New England Journal of Medicine 252:561-567, 1955.
43. Curran TL. Laryngeal carcinoma in Connecticut. AMA Archives of Otolaryngology 62:145-153, 1955.
44. Griswold MH. Hospitalization of cancer patients. Conn. Health Bulletin 69:11, 1955.
45. Griswold MH, Wilder CS, Cutler SJ, Pollack ES. Cancer in Connecticut. 1935-1951. Monograph, 1955.
46. Griswold MH. Environmental cancer in Connecticut: I. The survey project plan. Conn. Health Bulletin 70:4, 1956.
47. Griswold MH, Cutler SJ. The Connecticut cancer register - Seventeen years of experience. Conn. State Med. Journal XX:5:366, 1956.
48. Wilder CS. Environmental cancer in Connecticut: II. Differences in incidence of cancer among areas. Conn. Health Bulletin 70:6, 1956.
49. Griswold MD, Cutler SJ, Eisenberg H. Improvements in cancer survival rates. New England Journal Med. 254:1062-1068, 1956.
50. Keogh JR. Cancer mortality trends by sex, Conn. 1937-1954. Conn. Health Bulletin 70:8, 1956.
51. Shimkin MD, Griswold MH, Cutler SJ. Survival in untreated and treated cancer. Annals of Internal Med. 45:2, 1956.
52. Wilder CS. Estimated cancer survival rates confirmed. Conn. Health Bulletin 70:9, 1956.
53. Greenberg RA. Mass survey detected lung cancer in Connecticut, 1949-1953. Conn. State Med. Journal XX:11:857, 1956.
54. Eisenberg H. Cancer diagnosis in relation to hospital. Conn. Health Bulletin 70:12, 1956.
55. Keogh JR. Progress in cancer control evident from increased hospital study and care of cases. Conn. Health Bulletin 71:10:267-270, 1957.
56. Cutler SJ, Griswold MH, Eisenberg H. An interpretation of survival rates: Cancer of the breast. Journal Nat. Canc. Inst. 19:6, 1957.
57. Greenberg R. Trend in cancer incidence by sex and site, Conn., 1935-1954. Conn. Health Bulletin 72:3, 1958.
58. Ryan AJ, Griswold MH, Allen EP, Katzenstein R, Greenberg R, Keogh J, Wilder, C. Breast cancer in Conn. 1935-1953-Study of 8,396 proved cases. J.A.M.A. 167:3, 1958.
59. Eisenberg H, Greenberg RA, Yesner R. ABO blood groups and gastric cancer. J. Chron. Dis. 8:3:342-348, 1958.
60. Eisenberg H, Currie JB. Cancer mortality in later life. Conn. Health Bulletin 72:10, 1958.
61. Greenberg RA. The Connecticut Tumor Registry. Conn. Health Bulletin 73:2, 1959.
62. White C, Eisenberg H. ABO blood groups and cancer of the stomach. The Yale J. of Bio. and Med. 32:1, 1959.
63. Greenberg RA, Honeyman M. Lung cancer a growing problem. Conn Health Bulletin 73:9, 1959.
64. Cutler SJ, Ederer F, Griswold MH, Greenberg RA. Survival of breast cancer patients in Connecticut, 1935-1954. J. Nat. Canc. Inst. 23:5, 1959.
65. Cutler SJ, Ederer F, Griswold MH, Greenberg RA. Survival of patients with uterine cancer, 1935-1954. J. Nat. Canc. Inst. 24:3, l960.
66. Cutler SJ, Ederer F, Griswold MH, Greenberg RA. Survival of patients with ovarian cancer, 1935-1954. J. Nat. Canc. Inst. 24:3, 1960.
67. Mustacchi P, Cutler SJ. Survival of patients with cancer of the thyroid gland. JAMA 173:1795-1798, 1960.
68. Ederer F, Cutler SJ, Eisenberg H, Keogh J. Survival of patients with cancer of the stomach. Conn. 1935-1954. J. Nat. Canc. Inst. 25:5, 1960.
69. Keogh J. The systematic follow-up of cancer. Conn. Health Bulletin 74:11, 1960.
70. Ederer F, Cutler SJ, Eisenberg H, Keogh JR. Survival of patients with cancer of the large intestine and rectum, Connecticut. 1935-1954. J. Nat. Cancer Inst. 26:2, 1961.
71. Bailar JC III. Uterine cancer in Connecticut: Late deaths among five-year survivors. J. Nat. Cancer Inst. 27:2, 1961.
72. Axtell LM, Breslow L, Eisenberg H. Trends in survival rates of cancer patients: Connecticut and California. Nat. Cancer Inst. Monograph 6, 1961.
73. Bailar JC III, Rice SL. Survival of uterine cancer patients in different-sized hospitals. Public Health Reports 76:11, 1961.
74. Ryan AJ, Curry J, Eisenberg H. Castration following radical mastectomy for breast cancer - Prelimary study. Conn. Medicine XXVI:2:71, 1962.
75. Bailar JC III, Rice SL. Geographic variation in uterine cancer incidence in Connecticut. Public Health Reports 77:2, 1962.
76. Bailar JC, Honeyman MS, Eisenberg H. Incidence and mortality rates for leukemia and lymphoma. Public Health Reports 77:4, 1962.
77. Odoardo DF. Lung cancer mortality, 1949-1961. Conn. Health Bulletin 77:5, 1962.
78. Eisenberg H. Connecticut participates in international cancer studies. Conn. Health Bulletin 76:11, 1962.
79. Honeyman MS. The familial implications of breast cancer in man. Conn. Health Bulletin 76:12, 1962.
80. Kralits LA. Cancer statistics by the IBM data processing method. Conn. Health Bulletin 1963.
81. Campbell PC. The Connecticut Tumor Registry today - The growth of the registry. Conn. Health Bulletin 77:2, 1963.
82. Ederer F, Cutler SJ, Goldenberg IS, Eisenberg H. Causes of death among long-term survivors from breast cancer in Connecticut. J. Nat. Cancer Inst. 30:5, 1963.
83. Bailar JC III, Loury R, Goldenberg IS. A note on follow-ups of lost patients. National Cancer Institute Monograph 6:123-128, 1963.
84. Eisenberg H. Cancer control: Some opportunities for continued progress. Conn. Health Bulletin 1963.
85. Eisenberg H. Connecticut's contribution to the eighth international cancer congress. Conn Health Bulletin, 1963.
86. Bailar JC III. Incidence of independent tumors among uterine cancer patients. Cancer 16:7, 1963.
87. Eisenberg H, Mork T, Connelly PR. Cancer of the large intestine and rectum: Comparative data from Conn. & Norway, 1953-1958. Nat. Cancer Inst. Monograph 15:301-319. 1963.
88. Eisenberg H, Cutler SJ, Axtell L. Survival patterns for some forms of cancer. (Read at the 72nd annual meeting of the Assoc. of Life Ins. Medical Dires. of Am., Vol. XLVII. Oct. 16-18, 1963).
89. Greenberg RA. The occurrence of multiple primary cancers in Connecticut, 1935-1954. Conn. Health Bulletin 1963.
90. Eisenberg H, Keogh JR, Foote FM. Secular trends in survival: Five years and later: Cancer patients drawn from a defined population - Connecticut, U.S.A. Extrait de Acta Union International Contre XI X:6-7, 1963.
91. Barnett RN, Eisenberg H. Breast carcinoma: Histologic grading and survival in a large series of cases. Conn. Medicine 28:2:123, 1964.
92. Eisenberg H. The Connecticut Registry - Its importance and contributions to oncology. Conn. Medicine 28:2:119, 1964.
93. Kuehn PG, Beckett R, Eisenberg H, Reed JF. Epidermoid carcinoma of the perianal akin and anal canal - A review of 157 cases. New England J. of Med 270:614-617, l964.
94. Cutler SJ, Eisenberg H. Cancer in the ages. Annals of the N.Y. Academy of Science 114:2:771-781, 1964.
95. Mersheimer WL, Ringel A, Eisenberg H. Some characteristics of multiple primary cancers. Annals of the N.Y. Academy of Sciences 114:2:896-921, 1964.
96. Eisenberg H, Cutler SJ, Axtell L. Differential survival of cancer for selected sites. Proc. 8th International Congress of Life Assurance Med., Lucerne, Switzerland 1964.
97. Eisenberg H, Shames JM, Holloway WL, Barrett HS. Cancer of the bronchus and lung: Conn. 1935-1959. J. Chron. Dise 17:1033-1054, 1964.
98. Eisenberg H, Odorado DF, Campbell PC. Cancer in Conn. mortality data, 1949-1961. Monograph, 1964.
99. Cancer in Conn. - 1960. (Prepared by the staff of the Chronic Disease Control Section - H. Eisenberg, M.D., Chief). 1964.
100. Mason MJ, Bailar JC III, Eisenbenberg H. Geographic variation in the incidence of esophageal cancer. J. Chronic Dis 17:667-676, 1964.
101. Eisenberg H. Trends in mortality by age for selected cancer sites, 1949-1961. Conn. Health Bulletin 79:1, 1965.
102. Ederer F, Myers MH, Eisenberg H, Campbell PC. Temporal spatial distributions of leukemia and lymphoma in Conn. J. Nat. Cancer Inst. 35: 4, 1965.
103. Kuehn PG, Beckett R, Eisenberg H, Reed JF. Hematogenous metastases from epidermoid carcinoma of the anal canal. The Am. J. of Surg. 109:4:445-449, 1965.
104. Bailar JC III, Eisenberg H. Uterine tumors of unspecified origin. Cancer 18:5, 1965.
105. Cancer in Connecticut - 1961. (Prepared by the staff of the Chronic Disease Control Section - H. Eisenberg, M.D., Chief). Monograph, 1965.
106. Eisenberg H and staff of Chronic Disease Control Section: Cancer in Connecticut - Supplementary Mortality Data. 1949-1962. Monograph, 1965.
107. Eisenberg H, Heise H. End results in cancer of the prostate and the urinary bladder, 1940 to 1959. Presented at the 5th Nat. cancer conf. Published by J.B. Lippincott Co. 1965.
108. Bailar JC III, Thomas LB, Thomson AD, Eisenberg H, Vick RM. Morphology and survival rates of cervical cancer in Connecticut and southwest England. Nat. Cancer Inst. Monograph 19 - Study of Cancer and Other Chronic Diseases 1966.
109. Eisenberg H. The usefulness of the Conn. Central Tumor Registry. Conn. Medicine 30:6:412, 1966.
110. Eisenberg H. The value of a central tumor registry. Indian J. of Cancer 3:2:75-93, 1966.
111. Janus ZL, Bailar JC III, Eisenberg H. ABO blood groups and multiple cancers. Conn. Medicine 30:7:475, 1966.
112. Campbell P. Suicides among cancer patients. Conn. Health Bulletin 80:6, 1966.
113. Wynder EL, Graham S, Eisenberg H. Conference on the etiology of gastrointestinal tract cancer. Cancer 19:11:1561-1566, 1966.
114. Foote FM, Eisenberg H, Honeyman MS. Trends in cancer incidence and survival in Connecticut. Cancer 19:11, 1966.
115. Truax H, Barnett RN, Hukill PB, Campbell PC, Eisenberg H. The effect of inaccurate pathological diagnosis on survival statistics for melanoma - survey of cases in the Connecticut Tumor Registry. Cancer 19:11:1543-1547. 1966.
116. Eisenberg H and staff of Chronic Disease Control Section: Cancer in Connecticut, Incidence and Rates, 1935-1962. (Monograph published 1966).
117. Eisenberg H and staff of Chronic Disease Control Section: Cancer in Connecticut, 1963. (Monograph published 1966).
118. Eisenberg H, Goldenberg I. A measurement of the quality of survival of breast cancer patients in Connecticut, U.S.A. Reprinted from Clinical Evaluation of Breast Cancer Published by Academic Pr ess Inc. (London) Ltd, 1966.
119. Eisenberg H, Connelly R. Some preliminary data on the postmastectomy treatment of female breast cancer in Connecticut. Conn. Medicine 31:3:193, 1967.
120. Shedd DP, von Essen CF, Eisenberg H. Cancer of the nasopharynx in Connecticut: 1935 through 1959. Cancer 20:4:508-511, 1967.
121. Cutler SJ, Heise H, Eisenberg H. Childhood leukemia in Connecticut, 1940-1962. BLOOD 30:1, 1967.
123. Eisenberg H, Sullivan P, Foote FM. Trends in survival of digestive system cancer patients in Connecticut 1935 to 1962. Gastroenterology 53:4:528-546, 1967.
124. Janus ZL, Bailar JC III, Eisenberg H. Blood groups and uterine cancer. Am. J. of Epidemiology 86:3, 1967.
125. Moldow RE. A preliminary report - Leukemia case surveillance in Connecticut, July 1, 1966 - June 30, 1967. Conn. Health Bulletin 81:11, 1967.
126. Eisenberg H. Thoughts about "Cancer facts by experts." Conn. Health Bulletin 81:12, 1967.
127. Eisenberg H, Foote FM. Cancer trends as determined by the Connecticut State Tumor Registry. Progress in Clinical Cancer III. Edited by Irving M. Ariel, M.D, 1967.
128. Eisenberg H, Campbell P, Flannery J. Cancer in Connecticut, incidence characteristics 1935-1962. Published 1967.
129. Connelly RR. Cancer mortality among the foreign-born in Connecticut. Conn. Health Bulletin 81:10, 1967.
130: Eisenberg and staff of Chronic Disease Control Section: Cancer in Connecticut, 1964 Published 1967.
131. Shedd DP, von Essen CF, Eisenberg H, Connelly RR. Cancer of the floor of the mouth in Connecticut, 1935-1959. Cancer 21:1, 1968.
132. Shedd D, von Essen C, Ferraro R, Connelly RR, Eisenberg H. Cancer of tongue in Connecticut, 1935-1959. Cancer 21:1, 1968.
133. Berlin BB, Cornwell PM, Connelly RR, Eisenberg H. Radical perineal prostatectomy for carcinoma of the prostate: Survival in 143 cases treated from 1935-1958. The J. Urol. 99:97-101, 1968.
134. Shedd DP, von Essen CF, Connelly R R, Eisenberg H. Cancer of the buccal mucosa, palate, and gingiva, Connecticut, 1935-1959. Cancer 21:3, 1968.
135. Shedd DP, von Essen CF, Connelly RR, Eisenberg H. Cancer of the pharynx, Connecticut 1935-1959. Cancer 21:4, 1968.
136. Eisenberg H. Survival experience of cancer of the thyroid by various treatments as experienced in a total population group. Thyroid Cancer Conference, Lausanne, Switzerland. UICC Monog. Series, Vol. 12: Thyroid Cancer 1968.
137. Connelly RR, Campbell PC, Eisenberg H. Central registry of cancer cases in Connecticut. Public Health Reports 83:5:386-390, 1968.
138. Eisenberg H, Shambaugh E. Cancers of the gastrointestinal tract: Trends in incidence and mortality rates. In Proceedings, Sixth National Cancer Conference, Denver, Colorado 1968.
139. Hulme GW, Eisenberg H, Campbell PC. Carcinoma in-situ of the cervix in Connecticut, a review, 1949-1962. Am. J. of Obstetrics and Gynecology 102:3:415-425, 1968.
140. Kuehn PG, Eisenberg H, Reed JF. Epidermoid carcinoma of the perianal skin and anal canal. Cancer 22:5, 1968.
141. von Essen CF, Shedd DP, Connelly RR, Eisenberg H. Cancer of the larynx, Connecticut, 1935-1959. Cancer 22:6, 1968.
142. Moldow RE, Connelly RR. Epidemiology of pancreatic cancer in Connecticut. Gastroenterology 55:6:677, 1968.
143. Cuello C, Correa P, Eisenmberg H. Geographic pathology of thyroid carcinoma. Cancer 23:1:230-239, 1969.
144. Krackow J. Leukemia case surveillance in Connecticut, July 1, 1967 - June 30, 1968. Conn. Health Bulletin 83:3, 1969.
145. Cutler SJ, Connelly RR. Mammary cancer trends. Cancer 23:4:767-774, 1969.
146. Eisenberg H, Sullivan P, Connelly RR. Cancer in Connecticut - Survival experience 1935-1962. 1969.
147. Christine B. and staff of the Chronic Disease Control Section. Cancer in Connecticut, 1965. 1969.
148. Christine B, Sullivan P and Connelly R. Cancer in Connecticut, 1966. Conn. Health Bulletin 84:5, 1970.
149. Bailar JC III, Eisenberg H, and Mantel N. Time between pairs of leukemia cases. Cancer 25:1301-1303, 1970.
150. Christine B, Sullivan P, Connelly R and Foote F. Cancer incidence, mortality and survival in Connecticut during the 1960's. Connecticut Medicine 34:8:564-569, 1970.
151. Lipworth L, Abelin T and Connelly R. Socio-economic factors in the prognosis of cancer patients. Journal of Chronic Diseases 23:105-116, 1970.
152. Shedd DP, Von Essen CF, Connelly RR, and Eisenbert H. Cancer of the lip in Connecticut, 1935-1959. The Cancer Bulletin XXII:6, 1970.
153. Christine BW, Sullivan PD. Effect if cigarette smoking on Connecticut residents. Conn. Health Bulletin 85:1, 1971.
154. Christine B, Flannery J, Connelly R. Cancer in Connecticut, 1967. Conn. Health Bulletin 85:1:47-56, 1971.
155. Groff WH, Pitt TH, Christine BW. Cervical cancer and social rank in metropolitan Connecticut. Agricultural Experiment Station Bulletin. Research Report 34, 1971.
156. Sullivan PD, Christine BW, Connelly RR, Barrett H. Analysis of trends in age adjusted incidence rates of cancer for ten major sites, 1935-1965. The Am J of Pub Health 62:8:1065-1071, 1971.
157. Christine B, Flannery J, Sullivan P. Cancer in Connecticut, 1968. Conn. Health Bulletin 85:11, 1971.
158. Cutler SJ, Christine B, Barclay THC. Increasing incidence and decreasing mortality rates for breast cancer. Cancer 28:6, 1971.
159. Christine B, Flannery J. Sullivan P. Cancer in Connecticut. 1966-1968. Monograph, 1971.
160. Munoz N, Connelly RR. Time trends of intestinal and diffuse types of gastric cancer in the United States. Int. J. of Cancer 8:158:164, 1971.
161. Shanmugaratnum K, Muir CS, Tow SH, Cheng WC, Christine B. Pedersen E. Rates per 100,000 births and incidence of choriocarcinoma and malignant mole in singapore chinese and malays - Comparison with Conn., Norway and Sweden. Inter., J . of Cancer 8:165-175, 1971.
162. Christine B, Groff W, Pitt T, Chapple M. The relationship of incidence of cervical cancer and socioeconomic status in seven cities, 1959-1964. Conn. Med. 36:2, 1972.
163. Christine BW, Flannery JT, Sullivan PD. Cancer in Connecticut, 1969. Conn. Health Bulletin 86:4, 1972.
164. Christine BW, Sullivan PD, Flannery JT. Cancer in Connecticut, 1970. Conn. Health Bulletin 86:11, 1972.
165. Christine B, Chapple M, Nadeau D. Cancer of the cervix in Connecticut. Conn. Medicine 36:12:669-680, 1972.
166. Odell R, Sullivan P, Christine B. Mortality from diseases of the respiratory system in Conn., 1960-71. Conn. Health Bulletin 87:2, 1973.
167. Christine B, Sullivan P, Flannery J. Cancer in young Connecticut adults aged 15-29 years, 1950-1969. Published in the Proceedings of the Second International Symposium on Cancer Detection and Prevention in Bologna 1973.
168. Kryscio RJ, Myers MH, Prusiner ST, Heise HW, Christine BW. The space-time distribution of Hodgkin's Disease in Connecticut, 1940-69. J. of the Nat. Canc. Inst. 20:5, 1973.
169. Christine B, Sullivan P, Flannery J. Cancer in Connecticut 1971. Conn. Health Bulletin 87:8, 1973.
170. O'Conor GT, Correa T, Christine B, Axtell L, Myers M. Hodgkin's Disease in Connecticut: Histology and age distribution. National Cancer Institute Monograph 36:3-8, 1973.
171. Connelly RR, Christine B. A cohort study of cancer following infectious mononucleosis. Cancer Research 43:5, 1974.
172. Christine B. Cancer in Connecticut 1972. Conn. Health Bulletin 88:5, 1974.
173. Schoenberg BS, Christine BW. The Association of neoplasms of the colon and rectum with primary malignancies of other sites. Am. J. of Proctology 25:4, 1974.
174. Axtell L, Myers M, Christine B, Linden G. Trends in survival and classification for patients with leukemia diagnosed 1940-69. Published in J. Nat. Cancer Institute 53:2, 1974.
175. Curnen M, Varma A, Christine B. Turgeon L. Childhood leukemia and maternal infections during pregnancy. J. Nat. Ca. Inst. 53:4:943-947, 1974.
176. Cramer DW, Cutler SJ, Christine B. Trends in the incidence of endometrial cancer in the United States. Gynecologic Oncology 2:130-143, 1974.
177. Schoenberg BS, Christine BW. Multiple primary malignancies: Index tumors of the breast and reproductive organs. Reprinted from Excerpta Medical Inter. Congress Series 351:3. Cancer Epid., Environmental Factors. Proceedings of XI Inter. Can cer Congress, Florence 1974.
178. Christine BW. Cervical cancer screening. Conn. Health Bulletin 89:1, 1975.
179. Sullivan PD, Flannery JT. Analysis of data from the Connecticut Tumor Registry by several major factors of risk. Conn. Health Bulletin 89:2, 1975.
180. Dohrmann GJ, Farwell JR, Flannery JT. Childhood glioblastoma multiforme: Conn. 1935-1973. Conn. Health Bulletin 89:5, 1975.
181. Schoenberg B, Christine B, Whisnant J. Nervous system neoplasms and primary malignancies of other sites: The unique association between meningiomas and breast cancer. Neurology 25:8:705-712, 1975.
182. Meigs JW. The Connecticut cancer epidemiology unit. Connecticut Medicine 39:10, 1975.
183. Conn. State Medical Society, American Cancer Society, Conn. Division, and Conn. State Department of Health. Follow-Up of Cancer - A Handbook for Physicians. 1975.
184. Schoenberg BS, Schoenberg DG, Christine BW, Golmez MR. The epidemiology of primary intracranial neoplasms of childhood - a population study. Mayo Clinic Proc. 51, Jan. 1976.
185. Sullivan PD and Flannery JT. Changes in Connecticut's cancer rates, 1970-1974. Connecticut Health Bulletin 91:1, 1976.
186. Kantor ALF, Meigs JW, Heston JF, Flannery JT. Epidemiology of renal cell carcinoma in Connecticut, 1935-1973. J. Nat. Cancer Inst. 57:3, 1976.
187. Gershman ST, Flannery JT, Barrett H, Nadel RK, Meigs JW. Development of the Connecticut Tumor Registry. Connecticut Medicine 40:10, 1976.
188. Laskey PW, Meigs JW, Flannery JT. Uterine cervical carcinoma in Connecticut, 1935-1973: Evidence of two classes of invasive disease. J. Nat. Cancer Inst. 57:5, 1976.
189. Meigs JW, Laskey PW, Flannery JT. Evidence for regression for carcinoma in-situ and for a second form of invasive cervical cancer, Connecticut 1935-73. Geburtshilfe und Frauenheilkunde 36:554-569, 1976.
190. Kantor AF. Current concepts in the epidemiology and etiology of primary renal cell carcinoma. Journal of Urology 117, 1977.
191. Meigs JW. Epidemic lung cancer in women. JAMA 238:10, 1977.
192. Snyder DN, Heston JF, Meigs JW and Flannery JT. Changes in site distribution of colorectal carcinoma in Connecticut, 1940-1973. The American Journal of Digestive Diseases, New Series 22:9 , 1977.
193. Spencer RP and Flannery JT. The spleen in osteogenic sarcoma: A scan and autopsy survey. Clinical Nuclear Medicine 2:9, 1977.
194. Schoenberg BS, Fraumeni JF Jr, Greenberg RA, Christine B, Schoenberg DG. Multiple Primary Malignant Neoplasma, The Conn. Experience, 1935-1964. Springer-Verlag, Berlin-Heidelberg-New Yor k. 1977.
195. Curnen MGM, Turgeon L, Flannery JT, Varma AAO. Characteristics of mothers at high risk of leukemia developing in their children. Proceedings of the Third International Symposium on the < U>Detection and Prevention of Cancer 1976 1:991-997, 1977.
196. Farwell JR, Dohrmann GJ and Flannery JT. Central nervous system tumors in children. Cancer 40:3123-3132, 1977.
197. Jekel JF, Freeman DH and Meigs JW. A study of trends in upper arm soft tissue sarcomas in the State of Connecticut following the introduction of Alumadsorbed Allergenic Extract. Annals of Allergy 40:1, 1978.
198. Flannery JT and Sullivan PD. Female breast cancer in Connecticut - incidence, mortality, survival - 1935-1975. Conn. Health Bulletin 92:1, 1978.
199. Houghton A, Munster EW and Viola MV. Increased incidence of malignant melanoma after peaks of sunspot activity. Lancet April 8, 1978.
200. Dohrmann GJ, Farwell JR and Flannery JT. Oligodendrogliomas in children. Surg Neurol 10:21-25, 1978.
201. Weiss NS and Flannery JT. The relationship of marital status to survival from melanoma. Cancer 42:1:206-298, 1978.
202. Farwell JR, Dohrmann GJ and Flannery JT. Intracranial neoplasms in infants. Arch. Neurol 35:533-537, 1978.
203. Marrett LD, Elwood JM, Meigs JW and Flannery JT. Recent trends in the incidence and mortality of cancer of the uterine corpus in Connecticut. Gynecologic Oncology 6:183-195, 1978.
204. Harrington JM, Craun GF, Meigs JW, Landrigan PJ, Flannery JT, and Woodhull RS. Investigation of the use of asbestos cement pipe for public water supply and the incidence of gastrointestinal cancer in Connecticut, 1935-1973. American Journal of Epidemiology 107:96-103, 1978.
205. Thetford NA, McKernon RF, Flannery JT and Weiss T. Central Cancer Registry Data Management System. CH1480-3/79/0000-0804 IEEE. 1979.
206. Kantor AF, Curnen MGM, Meigs JW, Flannery JT. Occupations of fathers of patients with Wilm's Tumor. Journal of Epidemiology and Community Health 33:253-256, 1979.
207. Meigs JW, Walter SD, Heston JF, Millette JR, Craun GF, Woodhull RS, Flannery JT. Asbestos cement pipe and cancer in Connecticut 1955-1974. Journal of Environmental Health. Jan/Feb. 1980.
208. Lutes R, Meigs JW, Heston JF, Flannery JT. Increasing testicular cancer incidence in Connecticut. Connecticut Medicine 44:5, 1980.
209. Chung AF, Casey MJ, Flannery JT, Woodruff JM and Lewis JL. Malignant melanoma of the vagina - report of 19 cases. Obstetrics and Gynecology 55:6, 1980.
210. Houghton A, Flannery J, Viola MV. Malignant melanoma in Connecticut and Denmark. Int. J. Cancer 25:95-104, 1980.
211. Dix D and Cohen P. On the role of aging in cancer incidence. J. Theor. Biol. 82:000-000, 1980.
212. Testa MA, Meigs JW and Flannery JT. Mathematical modeling of cancer incidence rates: Linear models of colon cancer in Connecticut. Journal of Chronic Diseases 33:11/12:733-743, 1980.
213. Dorvlo AS, Enslein K and Salsburg D. A test of the hypothesis that time to tumor in humans fits the "One-Hit" model. Journal of Environmental Pathology and Toxicology 4:139-143, 1980.
214. Lewisohn HC, Meigs JW, Testa MJ and Flannery JT. The influence of occupational and environmental asbestos exposure on the incidence of malignant mesothelioma in Connecticut. Reprinted from Biological Effects of Mineral Fibres 2, 1980.
215. Roush GC, Meigs JW, Kelly J, Flannery JT and Burdo H. Sinonasal cancer and occupation: A case-control study. American Journal of Epidemiology III:2, 1980.
216. Pottern LM, Stone BJ, Day NE, Pickle, LW and Fraumeni JF Jr. Thyroid cancer in Connecticut, 1935-1975: An analysis by cell type. American Journal of Epidemiology 122:6, 1980.
217. Gershman ST, Most RS, Lewis JN and Marks JS. An epidemiologic review of cancer in an industrialized Connecticut town. Connecticut Medicine 45:1, 1981.
218. Kantor AF, Greene MH, Boice JD, Fraumeni JF Jr. Are Vince Alkaloids associated with myocardial infarction? The Lancet 1:1111, May 16, 1981.
219. Webber BL, Heise H, Neifeld JP, Costa J. Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma. Cancer 47:12, 1981.
220. Fox BH, Stanek III EJ, Boyd SC and Flannery JT. Suicide rates among cancer patients in Connecticut. J. Chron. Diseases 35:89-100, 1982.
221. Kantor AF, Li FP, Fraumeni JF, Curnen MGM, and Flannery JT. Childhood cancer in offspring of two Wilms tumor survivors. Medical and Pediatric Oncology 10:85-89, 1982.
222. Adler SN, Lyon DT and Sullivan PD. Adenocarcinoma of the small bowel clinical features, similarity to regional enteritis, and analysis of 338, documented cases. American Journal of Gastroenterology 77:5:326-330, 19 82.
223. Rousch GC, Kelly J, Meigs JW and Flannery JT. Scrotal carcinoma in Connecticut metalworkers. American Journal of Epidemiology 116:1, 1982.
224. Duffner PK, Cohen ME, and Flannery JT. Referral patterns of childhood brain tumors in the State of Connecticut. Cancer 50:8, 1982.
225. Kleinerman RA, Curtis RE, Boice JD, Flannery JT and Fraumeni JF. Second cancers following radiotherapy for cervical cancer. Journal of National Cancer Institute 69:5, 1982.
226. Stevens RG, Moolgavkar SH and Lee JAH. Temporal trends in breast cancer. The John Hopkins University School of Hygiene and Public Health 115:5, 1982.
227. Biggar RJ, Curtis RE, Hoffman DA and Flannery JT. Second primary malignancies following salivary gland cancers. Br. J. Cancer 47:383-386, 1983.
228. Ries LG, Pollack ES and Young Jr JL. Cancer patient survival: Surveillance, Epidemiology and End Results program, 1973-79. Journal of the National Cancer Institute 70:4, 1983.
229. Teta MJ, Lewinsohn HC, Meigs JW, Vidone RA, Mowad LZ and Flannery JT. Mesothelioma in Connecticut, 1955-1977. Journal of Occupational Medicine 25:10, 1983.
230. Wyshak G, Honeyman MS, Flannery JT and Beck AS. Cancer in mothers of dizygotic twins. JNCI 70:4, 1983.
231. Teta MJ, Walrath J, Meigs JW and Flannery JT. Cancer incidence among cosmetologists. JNCI 72:5, 1984.
232. Farwell J, Dohrmann GJ and Flannery JT. Tumors of the central nervous system in adolescents. American Family Physician 133-139, April 1984.
233. Brubaker LH, Wasserman LR, Goldberg JD, Pisciotta AV, McIntyre OR, Kaplan ME, Modan B, Flannery J and Harp R. Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols. American Jour nal of Hematology 16:367-373, 1984.
234. Curnen MGM, Thompson WD, Heston JF and Flannery JT. Cancer prevention: The tumor registry connection. Cancer Detection and Prevention 7:191-199, 1984.
235. Flannery JT, Boice JD Jr, Kleinerman RA and Curtis RE. The Connecticut Tumor Registry. Second Cancer in Relation to Radiation Treatment for Cervical Cancer 115-121, 1983.
236. Curnen MGM. Do cancer clusters exist? Connecticut Health Bulletin 98:2:38, 1984.
237. Farwell JR, Dohrmann GJ, and Flannery JT. Medulloblastoma in childhood: An epidemiological study. J. Neurosurg. 61:657-664, 1984.
238. Farwell J and Flannery JT. Cancer in relatives of children with central-nervous-system neoplasms. The New England Journal of Medicine 311:12, 1984.
239. Harvey EB, Boice JD Jr, Honeyman M and Flannery JT. Prenatal x-ray exposure and childhood cancer in twins. The New England Journal of Medicine 312:5, 1985.
240. Roush GC, Schymura MJ, Holford TR, White C, and Flannery JT. Time period compared to birth cohort in Connecticut incidence rates for twenty-five malignant neoplasms. Journal of the National Cancer Inst 74:4, 1985.
241. Hadjimichael OC, Meigs JW, Falcier FW, Thompson WD, and Flannery JT. Cancer risk among women exposed to exogenous estrogens during pregnancy. Journal of the National Cancer Institute 73:4, 1984.
242. Boice JD Jr, Day NE, Andersen A, Brinton LA, Brown R, Choi NW, Clarke EA, Coleman MP, Curtis RE, Flannery JT, Hakama M, Hakulinen T, Howe GR, Jensen OM, Kleinerman RA, Magnin D, Magnus K, Makela K, Malker B, Miller AB, Nelson N, Patterson CC, P ettersson F, Pompe-Kirn V, Primic-Zakelj M, Prior P, Ravnihar B, Skeet RG, Skjerven JE, Smith PG, Sok M, Spengler RF, Storm HH, Stovall M, Tomkins GWO, and Wall C. Second cancers following radiation treatment for cervical cancer. An international colla boration among cancer registries. Journal of National Cancer Institute 74:5, 1985.
243. Flannery JT, Janerich DT. The Connecticut Tumor Registry: Yesterday, today and tomorrow. Connecticut Medicine 49:11:709-713, 1985.
244. Marrett LD, Meigs JW, and Flannery JT. Bladder cancer in Connecticut: The role of cigarette smoking and other risk factors. Connecticut Medicine 49:11:718-726, 1985.
245. Janerich DT, Hadjimichael O and Flannery J. Strategy for elimination of invasive cervical cancer in Connecticut. Connecticut Medicine 49:11:746-753, 1985.
246. Curnen MGM, Thompson WD and Flannery JT. The Connecticut Tumor Registry: Potential for increasing its usefulness in etiologic research. Connecticut Medicine 49:11:753-759, 1985.
247. Meigs WJ, Marrett LD, Ulrich FU and Flannery JT. Bladder tumor incidence among workers exposed to benzidine: A thirty-year follow-up. Journal of National Cancer Institute 76:1, 1986.
248. Boice JD, Curtis RE, Kleinerman RA, Storm HH, Jensen OM, Jensen HS, Flannery JT, Fraumeni JF. Multiple primary cancers in Connecticut and Denmark. National Cancer Institute Monograph 68, 1985.
249. Stevens RG. Age and risk of acute leukemia. Journal of National Cancer Institute 76:5, 1986.
250. Heston JF, Kelly JAB, Meigs JW and Flannery JT. Forty-five years of cancer incidence in Connecticut: 1935-79. National Cancer Institute Monograph 70, 1986.
251. Kantor AF, McLaughlin JK, Curtis RE, Flannery JT and Fraumeni JF. Risk of second malignancy after cancers of the renal parenchyma, renal pelvis, and ureter. Cancer 58:5, 1986.
252. Brown LM, Pottern LM, Hoover RN, Devesa SS, Aselton P and Flannery JT. Testicular cancer in the United States: Trends in incidence and mortality. International Journal of Epidemiology 15:2:164-170, 1986.
253. Feldman AR, Kessler L, Myers MH and Naughton MD. The prevalence of cancer (Estimates based on the Connecticut Tumor Registry). The New England Journal of Medicine 315:22:1394-1397, 1986.
254. Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT and Fraumeni JF Jr. A population-based case-control study of thyroid cancer. Journal of National Cancer Institute 79:1, 1987.
255. Roush GC, Wairath J, Stayner LT, Kaplan SA, Flannery JT and Blair A. Nasopharyngeal cancer, sinonasal cancer and occupations related to formaldehyde: A case-control study. Journal of National Cancer Institute 79:6, 1987.
256. Polednak AP, Flannery JT and Janerich DT. Survival of children diagnosed with acute lymphoblastic leukemia in 1977-82 in Connecticut. Journal of Clinical Epidemiology 42:617-623, 1989.
257. Curtis RE, Boice JD Jr, Stovall M, Flannery JT and Moloney WC. Leukemia risk following radiotherapy for breast cancer. Journal of Clinical Oncology 7:1:21-29, 1989.
258. Rosenberg JM and Welch JP. Carcinoid tumors of the colon. American Journal of Surgery 149:775-779, 1985.
259. Gershman ST and Stolley PD. A case-control study of testicular cancer using Connecticut Tumor Registry data. International Journal of Epidemiology 17:4:738-742, 1988.
260. Farley TA and Flannery JT. Late-stage diagnosis of breast cancer in women of lower socioeconomic status. Public Health Implications 79:1508-1512, 1989.
261. Curtis RE, Boice JD Jr, Moloney WC, Ries LG and Flannery JT. Leukemia following chemotherapy for breast cancer. Cancer Research 50:2741-2746, 1990.
262. Chen J, Katz RV, Krutchkoff DJ. Epidemiology of oral cancer in Connecticut 1935 to 1985. Cancer 65:12, 1990.
263. Savoca PE, Ballantyne GH, Flannery JT, Modlin IM. Mucinous rectal cancer in the State of Connecticut: 1982-1986. Diseases of the Colon and Rectum 33:3, 1990.
264. Vukasin AP, Ballantyne GH, Flannery JT, Lerner E and Modlin IM. Increasing incidence of cecal and sigmoid carcinoma. Cancer 66:11, 1990.
265. Horwitz RI, Viscoli CM, Merino M, Brennan TA, Flannery JT and Robboy SJ. Clear cell adenocarcinoma of the vagina and cervix: Incidence, undetected disease, and diethylstilbestrol. Journal of Clinical Epidemiology 41:6:593-597, 1988.
266. Inskip PD, Harvey EB, Boice JD Jr, Stone BJ, Matanoski G, Flannery JT and Fraumeni JF Jr. Incidence of childhood cancer in twins. Cancer Causes and Control 2, 1991.
267. Dubrow R, Flannery JT and Liu W. Time trends in malignant melanoma of the upper limb in Connecticut. Cancer 68:8, 1991.
268. Wyshak G, Burdick E and Mosteller F. Technology assessment in the Connecticut Tumor Registry. International Journal of Technology Assessment in Health Care 7:2:129-133, 1991.
269. Ghali MH, Yoo KY, Flannery JT, Dubrow R. Association between childhood rhabdomyosarcoma and maternal history of stillbirths. International Journal Cancer 50:365-368, 1992.
270. Zheng T, Mayne ST, Flannery J. Letter to the editor (The time trends of multiple myeloma in Connecticut, 1935-1987). International Journal Cancer 50:163-164, 1992.
271. Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the contralateral breast after radiotherapy for breast cancer. The New England Journal of Cancer 326:12:781-785, 1992.
272. Travis LB, Gonzalez CL, Hankey BF, Jaffe ES. Hodgkin's disease following Non-Hodgkin's Lymphoma. Cancer 69:9:2337-2342, 1992.
273. Shelton D, Paturzo D, Flannery J, Gregorio D. Race, stage of disease, and survival with cervical cancer. Ethnicity and Disease 2:1:47-54, 1992.
274. Kern KA. Ten-year review of overall survival rates for stage I cutaneous melanoma in 3,009 residents of Connecticut. Connecticut Medicine 56:6:283-285, 1992.
275. Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwarts AG, Weyer P, Moloney WC, Hoover RN. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. The New England Jou rnal of Medicine 326:26:1745-1751, 1992.
276. Zheng T, Mayne ST, Holford TR, Boyle P, Liu W, Chen Y, Mador M, Flannery J. Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89. Cancer Causes and Control 3:481-492, 1 992.
277. Polednak A, Flannery JT, Janerich DT. Cervical cancer rates by population size of towns: Implications for cancer control programs. Journal of Community Health 16:6:315-323, 1991.
278. Polednak A, Flannery JT. Trends in breast cancer treatment in Connecticut. Connecticut Medicine 57:2:59-64, 1993.
279. Zheng T, Mayne ST, Holford TR, Boyle P, Liu W, Chen Y, Mador M, Flannery J. Time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989. Cancer 72:2:330-340, 1993.
280. Sartorelli AC, Janerich DT, Flannery JT, Addiss SS. Cancer trends and cancer prevention research in Connecticut. A Statistical and Epidemiological Report 1935-1986, 1992.
281. Polednak AP. Geographic Variation in the treatment of prostate cancer in Connecticut. International Journal of Technology Assessment in Health Care 9:2, 1993.
282. Polednak A and Flannery JT. Late-stage breast cancer in Connecticut's three largest cities. Connecticut Medicine 58:261-264, 1994.
283. Muir CS, Storm HH, Polednak A. Brain and other nervous system tumours. Cancer Surveys Volume 19/20: Trends in Cancer Incidence and Mortality. 1994 Imperial Cancer Research Fund. 0-87969-391-6/94.
284. Polednak AP. Cutaneous melanoma in Connecticut towns, 1989-91. Connecticut Medicine 58:9:515-518, 1994.
285. Polednak AP. Projected numbers of cancers diagnosed in the US elderly population, 1990 through 2030. American Journal of Public Health 84:8:1313-1318, 1994.
286. Zheng T, Mayne ST, Boyle P, Holford TR, Liu W and Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut, 1935-1988. Cancer 70:4:840-849, 1992.
287. Katz DL, Zheng T, Holford TR and Flannery J. Time trends in the incidence of renal carcinoma: Analysis of Connecticut Tumor Registry data, 1935-1989. Int J Cancer 58:57-63, 1994.
288. Chen Y, Zheng T, Holford TR, Berwick M and Dubrow R. Malignant melanoma incidence in Connecticut (United States): Time trends and age-period-cohort modeling by anatomic site. Cancer Causes and Control 5:341-350, 1 994.
289. Zheng T, Holford TR, Boyle P, Chen Y, Ward BA, Flannery J and Mayne ST. Time trend and the age-period-cohort effect on the incidence of histologic types of lung cancer in Connecticut, 1960-1989. Cancer 74:5:1556-1567, 1994.
290. State of Connecticut Department of Public Health and Addiction Services. Connecticut Tumor Registry. September 1994.
291. Flannery J and Polednak AP. Cancer Incidence in Connecticut 1980 - 1991. November, 1994.
292. Polednak AP. Trends in cancer incidence in Connecticut, 1935-1992. Cancer 74:10:2863-2872, 1994.
293. Polednak AP and Flannery JT. Brain, other central nervous system, and eye cancer. Cancer 75:1:330-337, 1995.
294. Flannery J and Polednak AP. Cancer Incidence in Connecticut by County and Town, 1989-91. January, 1995.
295. Zheng T, Holford TR, Ward BA, McKay L, Flannery J and Boyle P. Time trend in pancreatic cancer incidence in Connecticut, 1935-1990. International Journal Cancer 61:622-627, 1995.
296. Polednak AP and Flannery JT. Surveillance of cancer incidence in Connecticut counties and towns, 1989-91. Connecticut Medicine 59:6:323-330, 1995.
297. Gregorio DI, Flannery JT, and Hansen H. Stomach cancer patterns in European immigrants to Connecticut, United States. Cancer Causes and Control 3:215-221, 1992.
298. Morse DE, Flannery JT, Krutchkoff DJ and Eisenberg, E. An assessment of oral cancer underregistration at the Connecticut Tumor Registry. Oral Surgery Oral Medicine Oral Pathology 79:6:753-755, 1994.
299. Polednak AP. Declining use of radiotherapy for invasive cervical cancer in Connecticut: 1983-1990. Gynecologic Oncology 58:226-229, 1995.
300. Kleinerman RA, Boice, JD jr, Storm HH, Sparen P, Andersen A, Pukkala, E, Lynch, CF, Hankey, BF and Flannery JT. Second primary cancer after treatment for cervical cancer. Cancer 76:3:442-452, 1995.
301. Liu W, Kasl S, Flannery JT, Lindo A and Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes and Control 6:425-430, 1995.
302. Polednak, A.P. Re: Increased mortality from brain tumors: A combined outcome of diagnostic technology and change in attitude toward the elderly. American Journal of Epidemiology. Letter to the Editor, 140:1138-1140, 19 94.
303. Janerich DT, Hadjimichael O, Schwartz PE, Lowell DM, Meigs JW, Merino MJ, Flannery JT and Polednak AP. The screening histories of women with invasive cervical cancer, Connecticut. American Journal of Public Heal th 85:6:791-794, 1995.
304. Albertsen PC, Fryback DG, Storer BE, Kolon TF and Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274:8:626-631, 1995.
305. Berwick M, Dubin N, Luo S and Flannery J. No improvement in survival from melanoma diagnosed from 1973 to 1984. International Journal of Epidemiology 23:4:673-681, 1994.
306. Berwick M, Begg CB, Fine JA, Roush GC and Barnhill RL. Screening for cutaneous melanoma by skin self-examination. Journal of the National Cancer Institute 88:1:17-23, 1996.
307. Polednak AP. Interpretation of secular increases in incidence rates for primary brain cancer in Connecticut adults, 1965-1988. Neuroepidemiology 15:51-56, 1996.
308. Polednak AP. Time trends in incidence of brain and central nervous system cancers in Connecticut. Journal of the National Cancer Institute 83:22:1679-1681, 1991.
309. Polednak AP and Flannery JT. Family history of breast and ovarian cancer among breast-cancer patients in Connecticut Tumor Registry. Connecticut Medicine 60:2:67-70, 1996.
310. Davis FG, Malinski N, Haenszel W, Chang J, Flannery J, Gershman S, Dibble R and Bigner DD. Primary brain tumor incidence rates in four United States regions, 1985-1989: A Pilot Study. Neuroepidemiology 15:103-112, 1996.
311. Polednak AP. Familial testicular cancer in a population-based cancer registry. Urologia Internationalis 56:238-240, 1996.
312. Zheng T, Holford TR, Ma Z, Ward BA, Flannery J and Boyle P. Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992. International Journal of Cancer 65:723-729, 1996.
313. Polednak AP, Shevchenko IP and Flannery JT. Estimating breast cancer treatment charges in Connecticut. Connecticut Medicine 60:5:263-267, 1996.
314. Polednak AP. Reporting of occupational histories to a population-based cancer registry: mesothelioma in Connecticut, 1988-93. Journal of Registry Management 23:3:108-111, 1996.
315. Polednak AP. Cancer registry data on smoking habits and follow-up for childhood cancer patients: problems and prospects. Journal of Registry Management 23:3:127-131, 1996.
316. Holford TR, Zhang Z, Zhang T and McKay LA. A model for the effect of cigarette smoking on lung cancer incidence in Connecticut. Statistics in Medicine 15:565-580, 1996.
317. Polednak AP. Estimating breast cancer incidence in Hispanic women in Connecticut, 1989-1991. Ethnicity & Health 1:3:229-236, 1996.
318. Chen YT, Dubrow R, Holford TR, Zheng T, Barnhill RL, Fine J and Berwick M. Malignant melanoma risk factors by anatomic site: A case-control study and polychotomous logistic regression analysis. Int. J. Cancer 67:636-643, 1996.
319. Albertsen PC, Fryback DG, Storer BE, Kolon TF and Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. The Journal of Urology 156:127-132, July 1996.
320. Polednak AP. Using a population-based cancer registry in planning breast cancer screening programs in urban neighborhoods. Journal of Registry Management 179-182, November 1996.
321. Polednak AP. Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race. Cancer 79:1:99-103, January 1, 1997.
322. Zheng T, Holford TR, Chen Y, Ma JZ, Flannery J, Liu W, Russi M and Boyle P. Time trend and age-period-cohort effect on incidence of thyroid cancer in Connecticut, 1935-1992. International Journal of Cancer 67:504-509, 1996.
323. Zheng T, Holford TR, Chen Y, Ma JZ, Mayne ST, Liu W, Flannery J and Boyle P. Time trend and age-period-cohort effect on incidence of bladder cancer in Connecticut, 1935-1992. International Journal of Cancer 68:172-176, 1996.
324. Zheng T, Holford TR, Chen Y, Ma Z, Liu WL, Flannery J and Boyle P. Lymphocytic leukemias in Connecticut, USA: time trends and racial differences, 1935-92. Journal of Epidemiology and Biostatistics 1:4:000-000, 1996.
325. Zheng T, Holford TR, Chen Y, Jones BA, Flannery J and Boyle P. Time trend of female breast carcinoma in situ by race and histology in Connecticut, U.S.A. European Journal of Cancer 33:1:96-100, 1997.
326. Olsen GW, Gondek MR, Flannery J, Cartmill JB and Bodner KM. A thirty-eight year comparison of cancer incidence and mortality among employees at a Connecticut chemical plant. Connecticut Medicine 61:2:83-89, Feb. 1997.
327. Polednak AP, Shevchenko IP and Flannery JT. Estimating cancer incidence using a hospital discharge database versus a tumor registry. Journal of Registry Management 24:1:25-28, Feb. 1997.
328. Polednak AP and Flannery JT. Cancer incidence in Connecticut, 1980-94. March, 1997.
329. Polednak AP. Predictors of breast-conserving surgery in Connecticut, 1990-1992. Annals of Surgical Oncology 4:3:259-263, 1997.
330. Polednak AP. Trends in cancer incidence in Connecticut. Connecticut Medicine 61:4:211-218, April 1997.
331. Polednak AP. Trends in breast-conserving surgery in Connecticut: No effect of negative publicity. Connecticut Medicine 60:527-530, 1996.
332. Polednak AP. Estimating the prevalence of cancer in the United States. Cancer 80:136-141, 1997.
333. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW. Cigarette smoking and changes in the histopathology of lung cancer. Journal of the National Cancer Institute 89:1580-1586, November 5, 1997.
334. Barnhill RL, Fine JA, Roush GC and Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78:3:427-432, Aug. 1996. Errata 79:2:423, Jan. 1997.
335. Jones BA, Kasl SV, Curnen MGM, Owens PH and Dubrow R. Severe obesity as an explanatory factor for the black/white difference in stage at diagnosis of breast cancer. American Journal of Epidemiology 146:5:394-404, 1997.
336. Schildkraut JM, Bastos E and Berchuck A. Relationship between lifetime ovulatory cycles and overexpression of Mutant p53 in epithelial ovarian cancer. Journal of the National Cancer Institute 89:13:932-938, July 1997.
337. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ and Fraumeni Jr JF. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esoph agus and gastric cardia. Journal of the National Cancer Institute 89:17:1277-1284, Sept. 1997.
338. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S and Fraumeni Jr JF. Body mass index and risk of adenocarcinomas of the esophagus and gastric ca rdia. Journal of the National Cancer Institute 90:2:150-155, January 1998.
339. Albertsen PC, Nease Jr RF and Potosky AL. Assessment of patient preferences among men with prostate cancer. The Journal of Urology 159:158-163, January 1998.
340. Zahir KS, Quin JA, Brown W, Thomson JG and Dudrick, SJ. Trends in the incidence of upper extremity soft tissue malignanicies: A 40-year review of the Connecticut State Tumor Registry. Connecticut Medicine. 62:1:9-14, January 1998.
341. Byrne JL, Rasmussen SA, Steinhorn, SC, Connelly, RR, Myers MH, Lynch CF, Flannery J, Austin DF, Holmes FF, Holmes GE, Strong LC and Mulvihill JJ. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am. J . Hum. Genet. 62:42-52, 1998.
342. State of Connecticut Department of Public Health. Connecticut Tumor Registry Since 1935. February 1998.
343. Polednak AP. Incidence of selected cancers in Connecticut by county and town, 1990-94. March 1998.
344. Polednak AP, Zahir KS and Dudrick SJ. Letters to the editor regardig "Trends in the incidence of upper extremity soft tissue malignanicies: A 40-year review of the Connecticut State Tumor Registry." Connecticut Medicine. 62: 5:311-312, May 1998.
This bibliography was compiled by the Connecticut Tumor Registry, State of Connecticut Department of Public Health. 1998.